Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Dyserythropoietic Anemia”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT00152425
What this trial is testing

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Who this might be right for
Crohn's Disease
UCB Pharma 392
Post-approval studies (Phase 4)UnknownNCT01795794
What this trial is testing

Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC

Who this might be right for
CDA Type I
Soroka University Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT00730314
What this trial is testing

Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Sickle Cell DiseaseThalassemiaAnemia+9 more
Children's Hospital Los Angeles 25
Not applicableLooking for participantsNCT07206095
What this trial is testing

Integrative Diagnosis for SCD and Other RADs

Who this might be right for
Sickle Cell DiseaseThalassaemiaCongenital Dyserythropoietic Anemia (CDA)+6 more
Hospital Universitari Vall d'Hebron Research Institute 200
Early research (Phase 1)Study completedNCT01061645
What this trial is testing

Study of MOC31-PE in Antigen Positive Carcinomas

Who this might be right for
Carcinoma
Oslo University Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07471516
What this trial is testing

Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia

Who this might be right for
Congenital Dyserythropoietic Anemia (CDA)
Institute of Hematology & Blood Diseases Hospital, China 2
Testing effectiveness (Phase 2)Study completedNCT00001958
What this trial is testing

Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)

Who this might be right for
Beta ThalassemiaHemoglobinopathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Not applicableUnknownNCT01201135
What this trial is testing

GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis

Who this might be right for
Patients With Thalassemia Intermedia,Congenital Dyserythropoietic Anemia Type I
Wolfson Medical Center 80
Not applicableLooking for participantsNCT02964494
What this trial is testing

The Congenital Dyserythropoietic Anemia Registry (CDAR)

Who this might be right for
Congenital Dyserythropoietic Anemia (CDA)
Children's Hospital Medical Center, Cincinnati 10,000
Testing effectiveness (Phase 2)WithdrawnNCT05471492
What this trial is testing

Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Telavant, Inc.
Large-scale testing (Phase 3)Study completedNCT00152490
What this trial is testing

Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

Who this might be right for
Crohn's Disease
UCB Pharma 604
Not applicableUnknownNCT03983629
What this trial is testing

Registry of Congenital Dyserythropoietic Anemia

Who this might be right for
Congenital Dyserythropoietic Anemia
Lille Catholic University 200